Announcements Trials
Browse Landscape

Phase

Phase NA 229Phase 3 13Phase 2 11Phase 1 4Phase EARLY_PHASE1 2Phase 4 2Phase 1/2 2Phase 2/3 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 1Dermatologic 1

Conditions

Skin Neoplasms 1Melanoma 1Colonic Neoplasms 1Carcinoma, Basal Cell 1

Interventions

pembrolizumab 410Cyclophosphamide 394Carboplatin 306Gemcitabine 286Nivolumab 276Paclitaxel 274Cisplatin 252Radiotherapy 225Dexamethasone 210Bevacizumab 209fludarabine 192Docetaxel 187Rituximab 183Capecitabine 171Oxaliplatin 158Lenalidomide 157Fluorouracil 152Temozolomide 138Cytarabine 135Etoposide 128Irinotecan 124Cetuximab 123fludarabine phosphate 120Injections 118venetoclax 116Ipilimumab 115Doxorubicin 114Azacitidine 108130-nm albumin-bound paclitaxel 108Pemetrexed 107

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1/2 × Interventional × Methods × Clear all
NCT04035096 2019-07-29

The Effectiveness of High-dose Intravenous Vitamin c With Very Low Carbohydrate Diet for Terminal Colon Cancer Patients

National Taiwan University Hospital

Phase 1/2 Unknown
40 enrolled
Gastrointestinal

Colonic Neoplasms

NCT00403377 2015-10-01

Investigation of a Behavioral Substitute for Sunbathing

University of Massachusetts, Worcester

Phase 1/2 Completed
307 enrolled
Dermatologic

Carcinoma, Basal Cell, Melanoma, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡